Milestone Pharmaceuticals NMPA approval triggers $2 million milestone payment
Milestone Pharmaceuticals (NASDAQ:MIST) says NMPA approval triggers a $2 million milestone payment to the company.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.